Ireland· IE-PA-EU/1/09/521/008-009
Renvela 0.8 g Powder for oral suspension
A nalorphin product containing sevelamer carbonate, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Nalorphin is registered in 2 of 19 countries.
Countries holding a registration under ATC V03AB02 (nalorphin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Nalorphin · ATC V03AB02
2 / 19 countries
- Finlandprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Sevelamer carbonate
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Ireland (IE)
- ATC code
- V03AB02
- ATC class
- Nalorphin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/09/521/008-009
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nalorphin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRenvelaGenzyme Corporation
- CzechiaRENVELASanofi Winthrop Industrie, Gentilly
- BelgiumRenvela 0.8 gSanofi Winthrop Industrie
- SwedenRenvela 0,8 g Pulver till oral suspensionSanofi Winthrop Industrie
- FinlandRenvelaSanofi Winthrop Industrie
- NorwayRenvelaSanofi Winthrop Industrie
- GermanySevelamercarbonat AlAliud Pharma Gmbh
- CanadaACCEL-SEVELAMERACCEL PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Sevelamer Ratiopharm, Sevelamer Sandoz
- Belgium · Sevelamer Carbonate Ab, Sevelamer-Carbonaat Genthon
- Bulgaria · Sevelamer Sandoz, Севеламер Карбонат Heaton
- Cyprus · Sevelamer Ledpharm
- Czechia · Sevelamer Carbonate Heaton, Sevelamer Carbonate Viatris
- Germany · Sevelamercarbonat Al, Sevelamercarbonat Axiromed
- Denmark · Lovtelar, Sevelamer Sandoz
- Estonia · Sevelamer Auxilia
- Spain · Fosquel, Lovtelar
- Finland · Sevelamer Avansor
- France · Lovtelar, Sevelamer Carbonate Arrow
- United Kingdom (Northern Ireland) · Sevelamer Carbonate, Sevelamer Carbonate Aspire Pharma
- Greece · Lovtelar, Sevelamer Demo
- Croatia · Sevelamer Sandoz, Sevelamerkarbonat Pliva
- Hungary · Sevelamer Carbonate Pharmsol, Sevelamer Mensana Pharma
- Iceland · Renvela, Sevelamer Carbonate Winthrop
- Italy · Lovtelar, Sevelamer Aurobindo
- Liechtenstein · Renvela, Sevelamer Carbonate Winthrop
- Luxembourg · Sevemed
- Latvia · Sevelamer Carbonate Sandoz, Sevelamer Carbonate Synthon
- Netherlands · Sevelameercarbonaat Sandoz, Sevelameercarbonaat Viatris
- Norway · Renvela, Sevelamer Carbonate Winthrop
- Poland · Sewelameru Węglan Synthon
- Portugal · Sevelâmero Generis, Sevelâmero Mylan
- Romania · Carbonat De Sevelamer Heaton
- Sweden · Sevelamer Medical Valley, Sevelamer Sandoz
- Slovenia · Sevelamer Lek
- Slovakia · Sevelamer Carbonate Heaton, Sevelamer Carbonate Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7eacbbf8-f412-4199-b9aa-2ff4845140f1 GET /v1/drugs/7eacbbf8-f412-4199-b9aa-2ff4845140f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral suspension",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"V03AB02"
],
"strength": null,
"pa_number": "EU/1/09/521/008-009",
"substances": [
"Sevelamer carbonate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/09/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about nalorphin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.